Effects of selenium supplementation on antioxidant defense in Chronic Kidney Disease

Gabriela Cabral Vieira Freitas, Rita de Cássia Almondes Santana Lemos, Amanda Caroline Bandeira França, Laís Cristina Chaves dos Santos, Silva Maria Leite Matos Leão, Thaís Rodrigues Nogueira

Abstract


Introduction: Chronic kidney disease is characterized by the presence of inflammatory processes that contribute to homeostatic, physiological and functional changes. These conditions are mainly due to the decrease in antioxidant capacity, either due to the very common deficiency of selenium, or its loss through dialysis processes, which suggests that supplementation of this mineral may be beneficial for these patients. Objective: To investigate in the literature the effects of selenium supplementation on antioxidant activity in chronic renal patients. Methods: This is an integrative literature review, carried out by searching for original articles, in Portuguese, English and Spanish, indexed in the Pubmed and Lilacs databases. Results: Of the 108 articles, 5.5% (n=6) were included in this review, for full reading of the text. It was observed that 50% (n=3) of the studies demonstrated that selenium supplementation increased the activity of the enzyme GSH-Px. Another half (50%, n=3) of the articles, observed that a higher concentration of Se in the plasma of patients aged 12 to 80 years, reduced serum MDA levels. And only 16.6% (n=1) pointed to a significant increase in the activity of NK cells. Conclusion: Se supplementation was shown to be effective in improving the antioxidant defense of chronic renal patients.


Keywords


Inflammation; Kidney disease; Selenium; Nutritional supplement.

References


Alcalde, P.R. & Kirsztajn, G.M. (2018). Gastos do Sistema Único de Saúde brasileiro com doença renal crônica. Braz. J. Nephrol. (J. Bras. Nefrol.), 40(2),122-129.

Atakan, A., Macunluoglu, B., Kaya, Y., Ari, E., Demir, H., Asicioglu, E., Altunok, E.C. (2013). Decreased serum selenium levels are correlated with diminished coronary flow reserve among hemodialysis patients. Biol Trace Elem Res, 155(3), 333-8

Bahmani, F., Kia, M., Soleimani, A., Mohammadi, A.A., Asemi, Z. (2016). The effects of selenium supplementation on biomarkers of inflammation and oxidative stress in patients with diabetic nephropathy: a randomised, double-blind, placebo-controlled trial. Br J Nutr. 116(7), 1222-1228.

Bastos, M.G. & Kirstajn, G.M. (2011). Doença renal crônica: importância do diagnóstico precoce, encaminhamento imediato e abordagem interdisciplinar estruturada para melhora do desfecho em pacientes ainda não submetidos à diálise. J Bras Nefrol, 33(1), 93-108.

Bolignano, D., Cernaro, V., Gembillo, G., Baggetta, R., Buemi, M., D'Arrigo, G. (2017). Antioxidant agents for delaying diabetic kidney disease progression: A systematic review and meta-analysis. PLoS One. 12(6), 1-16.

Broman, M., Bryland, A., Carlsson, O. (2017). Trace elements in patients on continuous renal replacement therapy. Acta Anaesthesiol Scand. 61(6), 650-659.

Cai, Z., Zhang, J., Li, H. (2019). Selenium, aging and aging-related diseases. Aging Clin Exp Res. 31(8), 1035-1047.

Cao, J. & Singh, K. (2020). Integrating risk prediction models into chronic kidney disease care. Curr Opin Nephrol Hyperten, 29(2).

Centers for Disease Control and Prevention. National Chronic Kidney Disease Fact Sheet. (2017). Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention.

Oliveira, C.M.C., Kubrusly, M., Mota, R.S., Silva, C.A.B., Oliveira, V.N. (2010). Desnutrição na insuficiência renal crônica: qual o melhor método diagnóstico na prática clínica? J Bras Nefrol, 32(1), 57-70.

Cotinguiba, G.G., Silva, J.R.N., Azevedo, R.R.S., Rocha, T.J.M., Santos, A.F. (2013). Método de Avaliação da Defesa Antioxidante: Uma Revisão de Literatura. UNOPAR Cient Ciênc Biol Saúde, 15(3), 231-7.

González, S., Huerta, J.M, Álvarez-Uría, J., Fernández, S., Patterson, A.M, Lasheras, C. (2004). Serum selenium is associated with plasma homocysteine concentrations in elderly humans. J Nutr, 134 (7), 1736-40.

Greffin, S., André, M.B., Matos, J.P.S., Kang, H.C., Jorge, A.J.L., Rosa, M.L.G., Lugon, J.R. (2017). J Bras Nefrol, 39(3), 246-252

Guo, C.H, Wang, C.L, Chen, P.C, Yang, T.C. (2011). Linkage of some trace elements, peripheral blood lymphocytes, inflammation, and oxidative stress in patients undergoing either hemodialysis or peritoneal dialysis. Perit Dial Int, 31(5), 583-91.

Horta, H.H.L. & Lopes, M.L. (2017). Complicações decorrentes do tratamento dialítico: contribuição do enfermeiro no cuidado e educação ao paciente. Revista Enfermagem Contemporânea, 6(2), 221-227.

Junior, E.V.S., Costa, E.L., Matos, R.A., Cruz, J.S., Maia, T.F., Nunes, G.A., Boery, R.N.S.O., Boery, E.N. (2019). Epidemiologia da morbimortalidade e custos públicos por insuficiência renal. Rev enferm UFPE on line, 13(3), 647-54.

Ko, W.S., Guo, C.H., Yeh, M.S., Lin, L.Y., Hsu, G.S.W., Chen, P.C., Luo, M.C., Lin, C.Y. (2005). Blood micronutrient, oxidative stress, and viral load in patients with chronic hepatitis C. World J Gastroenterol, 11(30), 4697-4702.

National Kidney Foundation, KDIGO, Kidney Disease Improving Global Outcomes. (2012). Am J Kidney Dis, 3(1). Disponível em: http://kdigo.org/home/glomerulonephritis-gn/.

Obrador, G.T., Mahdavi-Mazdeh, M., Collins, A.J., Global Kidney Disease Prevention Network. et al. (2011). Establishing the Global Kidney Disease Prevention Network (KDPN): a position statement from the National Kidney Foundation. Am J Kidney Dis, 57(3), 361-70.

Pinto, M.B.S. (2009). Efeitos da suplementação com Castanha-do-Brasil (Bertholletia Excelsa H.B.K.) como fonte de selênio para pacientes em hemodiálise. Faculdade de Ciências Farmacêuticas da Universidade de São Paulo.

Sada, H., Kato, A., Sumimoto, R., Ohmori, H., Ohdan, H. (2016). Effects of nutritional supplementation with selenium and zinc on natural killer cell activity in hemodialysis patients: a single-arm study. Int Urol Nephrol. 48(8), 1377-1378.

Salehi, M., Sohrabi, Z., Ekramzadeh, M., Fallahzadeh, M.K., Ayatollahi, M., Geramizadeh, B., Hassanzadeh, J., Sagheb, M.M. (2013). Selenium supplementation improves the nutritional status of hemodialysis patients: a randomized, double-blind, placebocontrolled trial. Nephrol Dial Transplant, 28(3), 716-23.

Santos, C.M.C.; Pimenta, C.A.M.; Nobre, M.R.C. (2007). A estratégia PICO para a construção da pergunta de pesquisa e busca de evidências. Rev. Latino-Am. Enfermagem. 15(3), 508-511.

Sedighi, O., Zargari, M., Varshi, G. (2014) Effect of Selenium Supplementation on Glutathione Peroxidase Enzyme Activity in Patients With Chronic Kidney Disease: A Randomized Clinical Trial. Nephrourol Mon, 6(3).

Silva, A.G.S., Dantas, L.S.A., Nogueira, T.R., Freitas, B.J.S.A. (2020). Comportamento do Selênio e Atividade da Glutationa Peroxidase Dependente de Selênio na Fibrose Cística. Research, Society and Development, 9(4), 1-15.

Sociedade Brasileira de Nefrologia. Censo 2013 [Internet]. São Paulo: SBN; 2013 [citado 15 Mar 2016]. Disponível em: http://www.sbn.org.br

Stockler-Pinto, M.B., Lobo, J., Moraes, C., Leal, V.O., Farage, N.E., Rocha, A.V., Boaventura, G.T., Cozzolino, S.M., Malm, O., Mafra, D. (2012). Effect of Brasil nut supplementation on plasma levels of selenium in hemodialysis patients: 12 months of follow-up. J Renal Nutr, 22(4), 434-9.

Sociedade Brasileira de Nefrologia. Censo de diálise. 2017 [internet]. São Paulo;2017. Disponível em: www.censo-sbn.org.br.

Taraz, M., Taraz, S., Dashti-Khavidaki, S. (2015). Association between depression and inflammatory/anti-inflamatory cytokines in chronic kidney disease and end-stage renal disease patients: A review of literature. Hemodial Int, 19(1), 11-22.

Tonelli, M., Wiebe, N., Hemmelgarn, B., Klarenbach, S., Field, C., Manns, B., Thadhani, R., Gill, J., Alberta Kidney Disease Network. (2009). Trace elements in hemodialysis patients: a systematic review and meta-analysis. BMC Med. 7, 25-37.

Walston, J., Xue, Q., Semba, R.B., Ferrucci, L., Cappola, A.R., Ricks, M., Guralnik, J., Fried, L.P. (2006). Serum antioxidants, inflammation, and total mortality in older women. American Journal of Epidemiology, 163(1), 18-26.

Wiggins, J., & Patel, S. (2010). Management of chronic kidney disease in older adults. Aging Health, 6(1), 41-51.

Zachara, B.A., Gromadzinska, J., Zbrog, Z., Swiech, R., Wasowicz, W., Twardowska, E., Jablonska, E., Sobala, W. (2009). Selenium supplementation to chronic kidney disease patients on hemodialysis does not induce the synthesis of plasma glutathione peroxidase. Acta Biochim Pol., 56(1), 183-7.

Zachara, B.A., Koterska, D., Manitius, J., Sadowski, L., Dziedzicsko, A., Salak, A., Wasowicz, W. (2004). Selenium Supplementation on Plasma Glutathione Peroxidase Activity in Patients with End-Stage Chronic Renal Failure. Biological Trace Element Research, 97(1), 15-30.




DOI: http://dx.doi.org/10.33448/rsd-v9i5.3247

Refbacks

  • There are currently no refbacks.


Base de Dados e Indexadores: Base, Diadorim, Sumarios.org, DOI Crossref, Dialnet, Scholar Google, Redib, Doaj, Latindex, Portal de Periódicos CAPES

Research, Society and Development - ISSN 2525-3409

Licença Creative Commons
Este obra está licenciado com uma Licença Creative Commons Atribuição 4.0 Internacional

Rua Irmã Ivone Drumond, 200 - Distrito Industrial II, Itabira - MG, 35903-087 (Brasil) 
E-mail: rsd.articles@gmail.com